XORTX Therapeutics Inc Sustainability Reports
XORTX Therapeutics Inc. is a late-stage clinical pharmaceutical company focused on developing and commercializing innovative therapies to treat progressive kidney disease and gout. The company develops medications designed to manage aberrant purine metabolism and reduce high uric acid levels.
Sector: Manufacturing
Country: Canada
Exchange: TSX Venture Exchange
LEI: 254900RAT3XZPF9F9350
2 reports from 2022 to 2025